Andalusian Health Service Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04529226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Andalusian Health Service

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intellectual Disability (Phase 2)

Mental Disorders (Phase 2)

Psychotic Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 8